Part of the bean follows familiar metabolic routes.
Its digestible starch becomes glucose. Its protein supplies amino acids. Its minerals and vitamins enter systems that use the same nutrients from many other foods.
These contributions matter, but they are not the most distinctive part of the Bean’s Journey.
The distinctive part begins with what human digestion cannot recover.
Bean fiber, resistant starch, and certain oligosaccharides pass through the small intestine without being fully broken into absorbable sugars. Their energy and carbon remain largely inaccessible to human enzymes.
Then the microbiome takes over.
Microorganisms ferment this material and release short-chain fatty acids, principally acetate, propionate, and butyrate. These are microbial products, but human cells can absorb and use them.
The microbiome has returned part of the bean to us in a new form.
This is the governing principle of the chapter:
The bean makes its distinctive contribution to human metabolism when the microbiome converts otherwise inaccessible carbohydrate into butyrate for local colonocyte metabolism and acetate for wider metabolic use.
The Bean’s Journey Continues: two routes leave the intestine
The bean now follows two metabolic routes.
The first begins in the small intestine. Digestible starch becomes glucose, enters blood, and joins the body’s general management of carbohydrate. Amino acids from bean protein join the common amino-acid pool used to build and replace proteins and other nitrogen-containing molecules.
Many foods enter these same routes.
The second route begins in the colon. Bean carbohydrate that escaped human digestion becomes food for microorganisms. They dismantle it through enzyme systems that human cells do not possess. Fermentation allows the microbial community to capture some of its energy.
The resulting short-chain fatty acids cross from the microbial ecosystem into human biology.
Here the bean changes identity once more:
bean carbohydrate → microbial fermentation → butyrate and acetate → human metabolism
Butyrate and acetate then travel in different directions.
Butyrate is used mainly near its site of production, especially by colonocytes. Acetate is more likely to pass through the intestinal wall, enter portal blood, and become available to the liver and other tissues.
One supports a local metabolic relationship.
The other joins whole-body metabolic circulation.
The part of the bean we cannot digest is not metabolically lost
Human digestive enzymes can break the accessible bonds in ordinary starch, protein, and fat. They cannot break many of the bonds that hold dietary fiber together. Some starch also resists digestion because of its molecular structure, its physical enclosure within the food, or changes that occur during cooking and cooling.
Beans deliver several forms of this resistant carbohydrate at the same time.
They contain plant-cell-wall polysaccharides, resistant starch, and oligosaccharides such as raffinose-family sugars. The amount reaching the colon varies with bean variety, processing, cooking, cooling, chewing, and the person’s digestion.
From the human digestive perspective, this material has escaped.
From the microbial perspective, it has arrived.
The colon contains organisms with enzymes capable of opening these structures. Some organisms release smaller fragments. Others consume those fragments. Still others use the products released by neighboring organisms.
Through this division of labor, carbon that could not enter the body as glucose becomes available as microbial metabolites.
Fermentation is therefore a form of metabolic recovery.
Fermentation gives the bean a second metabolic life
Microbial fermentation does not simply dissolve fiber.
It rearranges the bean’s carbon.
As microorganisms extract energy, they transfer carbon and electrons into several end products. Acetate, propionate, and butyrate are the major short-chain fatty acids, although their proportions vary among people and substrates.
Acetate is usually produced in the greatest amount. Butyrate is produced in smaller quantities but has a particularly important local relationship with the colonic epithelium. Propionate is absorbed and used largely by the liver, but it is not the central metabolic character in this chapter.
The production of one short-chain fatty acid may also depend on another.
Some microbes make acetate. Other microbes can use acetate together with additional fermentation products to make butyrate. This exchange is called cross-feeding.
The bean is not converted by one organism through one pathway.
Its metabolic value is unlocked by a community.
Butyrate returns energy directly to the colonocyte
The cells lining the colon sit beside the microbial ecosystem but remain separated from it by mucus and the epithelial surface.
Butyrate crosses that surface through diffusion and transport systems. Once inside a colonocyte, it can be converted to butyryl-CoA and then to acetyl-CoA. Its carbon enters mitochondrial pathways that transfer energy into ATP.
This is the bean’s most direct and distinctive contribution to colonocyte metabolism:
The human cell cannot digest the bean’s resistant carbohydrate, but it can oxidize the butyrate made from it.
The microbiome performs the chemical conversion that makes this recovery possible.
Classic experiments with colonocytes isolated from human surgical tissue showed that butyrate could account for a large portion of their oxygen consumption under the experimental conditions.[1] These isolated-cell measurements do not tell us exactly what fraction of a living person’s colonocyte energy came from a particular meal.
They establish the metabolic capacity: human colonocytes can use butyrate extensively as an oxidative fuel.
Butyrate becomes ATP—and changes the local environment
Inside mitochondria, acetyl-CoA derived from butyrate enters the citric-acid cycle. High-energy electrons move to the respiratory chain. Oxygen is consumed, and the resulting proton gradient drives ATP production.
The ATP supports the ordinary work of the colonocyte: maintaining ion gradients, transporting molecules, renewing cellular components, and preserving the organized epithelial surface.
But butyrate oxidation changes more than the cell’s ATP supply.
By consuming oxygen, colonocytes help limit the amount that diffuses toward the intestinal lumen. The lumen is normally a low-oxygen environment in which anaerobic fermenting communities can thrive. Thus microbial production of butyrate and colonocyte consumption of butyrate can help sustain the conditions in which fermentation continues.
The relationship forms a metabolic loop:
bean substrate feeds anaerobic microbes → microbes make butyrate → colonocytes oxidize butyrate and consume oxygen → the low-oxygen habitat supports anaerobic fermentation
This loop has been characterized most fully in experimental models. Its components are biologically plausible in humans, but the complete sequence has not been quantified after an ordinary bean meal.
The mechanism nevertheless shows why the location of metabolism matters.
The bean’s carbon supports the tissue facing the place where that carbon was transformed.
Butyrate influences gene regulation and provides fuel
Chapter 10 showed that butyrate can inhibit histone deacetylases and influence gene regulation.
Chapter 11 now reveals the other side of the same molecule.
Butyrate can be burned.
Whether it acts mainly as fuel or accumulates enough to affect regulatory enzymes depends partly on the receiving cell’s metabolism. A colonocyte that rapidly oxidizes butyrate creates a different intracellular exposure from a cell that uses it poorly.
Experiments comparing normal and cancerous colon-cell metabolism demonstrated this principle. Differences in butyrate oxidation changed its accumulation, its effect on histone acetylation, and the cellular response.[2]
The study does not show that beans treat cancer. It shows something essential to the Bean’s Journey:
A metabolite’s regulatory effect depends on its metabolic fate.
The same butyrate molecule can participate in both energy metabolism and gene regulation.
Most butyrate is used before it reaches the wider body
If butyrate is produced in the colon, why is relatively little found in peripheral blood?
Because the intestinal tissue and liver remove much of it before it can enter the general circulation.
In a stable-isotope study of 12 healthy adults, researchers delivered labeled short-chain fatty acids directly to the colon and traced their appearance and metabolic fate. Only about 2 percent of the administered butyrate reached systemic circulation.[3]
The experiment used a defined metabolite dose rather than beans, and it did not measure natural production from fermentation. Its result nevertheless clarifies the route.
Low circulating butyrate does not mean that little was produced or used.
It may mean that the molecule was consumed near its place of origin.
For the bean, butyrate is principally a local metabolic contribution.
Acetate carries the bean’s carbon beyond the colon
Acetate follows a different path.
It is generally the most abundant short-chain fatty acid produced during fermentation, and human tissues extract a smaller proportion of it during its first passage from the colon.
In the same stable-isotope study, approximately 36 percent of colonic acetate reached systemic circulation—far more than propionate or butyrate.[3]
Once in blood, microbial acetate mixes with acetate produced by human metabolism and with acetate arising from other sources. At that point, the circulation does not label one molecule as from the bean.
The bean-derived contribution has joined the body’s acetate pool.
Tissues can convert acetate to acetyl-CoA. That acetyl-CoA can be oxidized for energy or used as a substrate in biosynthetic reactions. Which route dominates depends on tissue, concentration, energy state, hormones, and competing fuels.
Human tracer studies show that circulating acetate turns over rapidly and that much of its carbon is oxidized to carbon dioxide.[3,4] In the colonic-delivery experiment, less than 15 percent of labeled acetate entered fatty acids and less than 1 percent entered cholesterol; oxidation was the major measured fate.[3]
This provides the second central metabolic route of the Bean’s Journey:
The microbiome converts inaccessible bean carbohydrate into acetate, and part of that acetate enters whole-body circulation and energy metabolism.
Acetate changes the body’s acetate supply, not a single metabolic switch
It would be too simple to say that bean-derived acetate activates one pathway or produces one health effect.
Acetate is a normal intermediate in human metabolism. It can be produced from several sources and used by several tissues. The body manages it within a large, changing flow of acetyl-CoA and energy substrates.
Fermentation adds an exogenous source: carbon arriving from the colon because microorganisms processed dietary material that human enzymes could not digest.
That additional acetate may increase the amount entering circulation after fermentation. It then contributes to whole-body acetate turnover—the continuous production, uptake, conversion, and oxidation of acetate.
The effect cannot be predicted from bean composition alone.
We must know how much resistant material reached the colon, how the microbiome fermented it, how much acetate was produced, how much the intestinal tissue and liver extracted, and what the rest of the body did with the amount that remained.
The important contribution is not a targeted command.
It is an additional metabolic supply created by the microbiome.
The microbiome decides the proportion returned as butyrate and acetate
Not every person converts the same bean into the same short-chain-fatty-acid mixture.
Microbial composition matters. So do transit time, intestinal pH, prior diet, the quantity and structure of substrate, and competition among organisms. Acetate made by one population may leave the colon or become material for butyrate production by another.
Laboratory fermentation of polysaccharides from several cooked common-bean varieties produced acetate, propionate, and butyrate, with acetate the most abundant product and the proportions differing by bean variety.[5]
This establishes that common-bean substrates can support these pathways in human fecal microbial communities.
It does not measure production inside the living human colon.
Human dietary studies support the broader relationship between resistant starch and fermentation. In a controlled crossover study of 11 adults, a high-resistant-starch diet increased fecal output of both acetate and butyrate.[6] Fecal measurements are an imperfect estimate of production because short-chain fatty acids are continuously absorbed and used before stool is passed.
The evidence therefore supports the pathway while leaving its exact yield after a serving of beans uncertain.
The bean supplies the opportunity.
The microbiome determines much of the conversion.
Why glucose is not the central story of this chapter
The bean’s digestible starch still matters.
It becomes glucose more gradually than carbohydrate from many highly refined foods because the cooked bean retains cellular structure, fiber, and resistant starch. Bean-containing meals have produced lower post-meal glucose responses than equal-carbohydrate rice meals in small randomized crossover studies.[7,8]
That is an important property of the whole bean.
But once absorbed, bean-derived glucose enters the same metabolic pool as glucose derived from other foods. The body does not maintain a separate pathway for bean glucose.
Butyrate and acetate tell a more distinctive story.
They exist in this journey because the bean met the microbiome. Human cells received chemical forms that were not present in the cooked bean and could not have been produced by human digestion alone.
This is where microbial transformation most clearly generates new metabolic substrates from food.
Following the bean’s carbon requires tracing every handoff
To establish the complete pathway in people, researchers would need to follow labeled carbon through successive stages:
- from a defined bean carbohydrate;
- through escape from small-intestinal digestion;
- into microbial fermentation;
- into butyrate or acetate;
- across the intestinal wall;
- into colonocyte or whole-body metabolism; and
- finally into ATP production, biosynthesis, storage, or carbon dioxide.
Existing experiments establish many of these steps separately.
Bean analyses identify resistant substrates. Fecal microbial experiments demonstrate fermentation. Human studies with resistant starch show changes consistent with short-chain-fatty-acid production. Isolated human colonocytes oxidize butyrate. Stable-isotope studies show that colonic short-chain fatty acids enter human metabolism and reveal their different systemic availability.
What remains difficult is connecting every step quantitatively after an ordinary bean meal in the same people.
That gap should limit numerical claims.
It does not erase the biological pathway.
The Bean’s Journey: the microbiome returns inaccessible carbon
The bean entered the colon carrying carbon that human digestion had not recovered.
The microbiome converted that material into molecules human cells could use.
Butyrate traveled the shorter route. Colonocytes absorbed it and could oxidize it to acetyl-CoA, capture its energy as ATP, and alter the local metabolic environment. Because so much butyrate is extracted locally, little reached the wider circulation.
Acetate traveled farther. A larger fraction entered systemic blood, mixed with the body’s acetate pool, and became available for oxidation and biosynthesis in other tissues.
These two routes reveal the bean’s distinctive metabolic contribution:
butyrate supports metabolism at the colonic surface; acetate extends microbial recovery of bean carbon into whole-body metabolism
The contribution is not made by the bean alone.
It emerges from the bean–microbiome–human partnership.
The Bean at This Stage
Part of the bean that seemed unavailable to human digestion has re-entered the journey.
Microorganisms unlocked its resistant carbohydrate and returned the carbon as short-chain fatty acids.
Butyrate became a local fuel and regulator for colonocytes. Acetate became a more widely circulating metabolic substrate. Their different fates were determined by the site of production, microbial cross-feeding, intestinal extraction, liver uptake, and the needs of receiving tissues.
The bean has not simply supplied calories.
Through microbial transformation, it has supplied new metabolic possibilities.
Next — Tissue Function: When the Bean Changes What the Body Does
Butyrate can support colonocyte metabolism, and acetate can enter wider metabolic circulation.
The next question is whether these cellular events change what tissues and organs actually do.
The next chapter follows the Bean’s Journey from microbial and cellular metabolism to intestinal barrier function, glucose regulation, immune activity, vascular function, and other outcomes that can be measured in a person.
Notes and selected references
- Roediger WEW. Role of anaerobic bacteria in the metabolic welfare of the colonic mucosa in man. Gut. 1980;21(9):793–798. doi:10.1136/gut.21.9.793.
- Donohoe DR, Collins LB, Wali A, Bigler R, Sun W, Bultman SJ. The Warburg effect dictates the mechanism of butyrate-mediated histone acetylation and cell proliferation. Molecular Cell. 2012;48(4):612–626. doi:10.1016/j.molcel.2012.08.033.
- Boets E, Gomand SV, Deroover L, et al. Systemic availability and metabolism of colonic-derived short-chain fatty acids in healthy subjects: a stable isotope study. Journal of Physiology. 2017;595(2):541–555. doi:10.1113/JP272613.
- Simoneau C, Pouteau E, Maugeais P, Marks L, Ranganathan S, Champ M, Krempf M. Measurement of whole body acetate turnover in healthy subjects with stable isotopes. Biological Mass Spectrometry. 1994;23(7):430–433. doi:10.1002/bms.1200230707.
- Campos-Vega R, Reynoso-Camacho R, Pedraza-Aboytes G, et al. Chemical composition and in vitro polysaccharide fermentation of different beans (Phaseolus vulgaris L.). Journal of Food Science. 2009;74(7):T59–T65. doi:10.1111/j.1750-3841.2009.01292.x.
- Phillips J, Muir JG, Birkett A, et al. Effect of resistant starch on fecal bulk and fermentation-dependent events in humans. American Journal of Clinical Nutrition. 1995;62(1):121–130. doi:10.1093/ajcn/62.1.121.
- Thompson SV, Winham DM, Hutchins AM. Bean and rice meals reduce postprandial glycemic response in adults with type 2 diabetes: a cross-over study. Nutrition Journal. 2012;11:23. doi:10.1186/1475-2891-11-23.
- Winham DM, Hutchins AM, Thompson SV. Glycemic response to black beans and chickpeas as part of a rice meal: a randomized cross-over trial. Nutrients. 2017;9(10):1095. doi:10.3390/nu9101095.